SWOT Analysis for Inhibrx Biosciences Inc.

Consistent Highest Return Stocks over Five Years
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over the Quarter (3 Months)
Relative Outperformance versus Industry over 1 Year
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
New 52 week high today
Relative Outperformance versus Industry over 10 Years
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Companies with Low Debt
Companies with reducing Debt
Increasing profits every quarter for the past 2 quarters
Top Gainers
Stock with Low PE (PE < = 10)
Highest Recovery from 52 Week Low
Stocks Outperforming their Industry Price Change in the Quarter

Red Flag: Companies with weak Sloan Ratio
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Declining Net Cash Flow : Companies not able to generate net cash